Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pulmonx (LUNG) Profit After Tax (2019 - 2025)

Pulmonx (LUNG) has disclosed Profit After Tax for 7 consecutive years, with -$14.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Profit After Tax rose 1.32% to -$14.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$56.8 million, a 0.62% increase, with the full-year FY2024 number at -$56.4 million, up 7.31% from a year prior.
  • Profit After Tax was -$14.0 million for Q3 2025 at Pulmonx, up from -$15.2 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$10.2 million in Q3 2021 to a low of -$16.2 million in Q2 2023.
  • A 5-year average of -$14.1 million and a median of -$14.2 million in 2022 define the central range for Profit After Tax.
  • Peak YoY movement for Profit After Tax: crashed 163.76% in 2021, then grew 13.31% in 2024.
  • Pulmonx's Profit After Tax stood at -$13.0 million in 2021, then dropped by 9.82% to -$14.3 million in 2022, then grew by 2.77% to -$13.9 million in 2023, then grew by 5.13% to -$13.2 million in 2024, then fell by 5.94% to -$14.0 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Profit After Tax are -$14.0 million (Q3 2025), -$15.2 million (Q2 2025), and -$14.4 million (Q1 2025).